Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
XORTX Therapeutics Inc.
Market Cap
$490141.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$524770.00
Operating Margin
-8567.94%
TTM Avg
-8664.53%
3Y Avg
-8990.40%
5Y Avg
-6121.14%
Market Cap
$552749.00
Operating Margin
-20757.65%
TTM Avg
-10953.08%
3Y Avg
-5758.86%
5Y Avg
-3862.92%
Market Cap
$381940.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-952.12%
5Y Avg
-1206.12%
Market Cap
$380715.00
Operating Margin
-51515.17%
TTM Avg
-74429.96%
3Y Avg
-54994.21%
5Y Avg
-36749.57%
Market Cap
$664522.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$242924.00
Operating Margin
-1022.08%
TTM Avg
-791.13%
3Y Avg
-582.66%
5Y Avg
-578.16%
Market Cap
$812262.00
Operating Margin
N/A
TTM Avg
-1.14%
3Y Avg
-4.66%
5Y Avg
-4.48%
Market Cap
$812496.00
Operating Margin
N/A
TTM Avg
-409.01%
3Y Avg
-308.21%
5Y Avg
-246.38%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| XORTX Therapeutics Inc. (XRTX) | $490141.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| VivoSim Labs, Inc. (VIVS)vs › | $524770.00 | -8567.94% | -8664.53% | -8990.40% | -6121.14% |
| HCW Biologics Inc. (HCWB)vs › | $552749.00 | -20757.65% | -10953.08% | -5758.86% | -3862.92% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | 0.00% | 0.00% | -952.12% | -1206.12% |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | -51515.17% | -74429.96% | -54994.21% | -36749.57% |
| CDT Equity Inc. (CDT)vs › | $664522.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | -1022.08% | -791.13% | -582.66% | -578.16% |
| Ridgetech, Inc. (RDGT)vs › | $812262.00 | N/A | -1.14% | -4.66% | -4.48% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $812496.00 | N/A | -409.01% | -308.21% | -246.38% |
| Decoy Therapeutics Inc. (DCOY)vs › | $838967.00 | 0.00% | 0.00% | 0.00% | -24.80% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-05-31 | 0.00% |
| 2017-02-28 | 0.00% |
| 2016-11-30 | 0.00% |
| 2016-08-31 | 0.00% |
| 2016-05-31 | 0.00% |
| 2016-02-29 | 0.00% |
| 2015-11-30 | 0.00% |
| 2015-08-31 | 0.00% |
| 2015-05-31 | 0.00% |
| 2015-02-28 | 0.00% |
| 2014-11-30 | 0.00% |
| 2014-08-31 | 0.00% |
| 2014-05-31 | 0.00% |
